JAK2 and lung adenocarcinoma: To investigate the potential mechanism by which PRDM5 deregulation promoted the proliferation of lung adenocarcinoma cells, we tested the expression levels of components of the JAK2/STAT3 pathway in A549 cells overexpressing PRDM5.